The Impacts of Pulmonary Rehabilitation Therapy on Patients After Thoracic Surgery
VATSMIPMEP
The Efficacy of Home-Based Pulmonary Rehabilitation Training in Aged Patients With Lung Tumor After Video-assisted Thoracic Surgery:A Clinical Randomized Trial
1 other identifier
interventional
36
1 country
2
Brief Summary
The advantages of thoracoscopic surgery include smaller wounds, fewer postoperative complications, and shortened hospital stay. However,complications such as pain, pulmonary function insufficiency, pneumonia,postoperative pneumothorax, persistent air leakage, subcutaneous emphysema, cough, and hemoptysis may occur in older patients after thoracoscopic surgery. Pulmonary rehabilitation has been demonstrated by evidence-base medicine could effectively reduce pulmonary complications and dyspnea as well as improve lung function, quality of life, exercise ability, and functional status of patients after traditional heart and thoracic surgery. Studies have suggested that pulmonary rehabilitation should be performed for at least 4 weeks to optimize the training effect .However, most patients who undergo thoracoscopic surgery were discharged within 3-5 days. Such a short hospital stay impeded the delivery of pulmonary rehabilitation. Home-based pulmonary rehabilitation appeared to be an option for these patients The purpose of this study is to determine whether Pulmonary rehabilitation are effective on patients who had thoracic surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2016
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 31, 2016
CompletedFirst Submitted
Initial submission to the registry
April 12, 2016
CompletedFirst Posted
Study publicly available on registry
April 29, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2017
CompletedResults Posted
Study results publicly available
November 3, 2020
CompletedNovember 3, 2020
October 1, 2020
1 year
April 12, 2016
December 15, 2017
October 10, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Discharge 2weeks Exercise Capacity
Exercise capacity as assessed by 6 min walking test(M).The 6-min walk test (6 MWT) is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6-minute walk distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise . The 6 MWT provides information regarding functional capacity, response to therapy and prognosis across a broad range of chronic cardiopulmonary conditions .The normal range in aged patients 60-69 y(male 572 m,female 538 M),70-79 y(male 527 m,female 471 M),80-89 y(male 417 m,female 392 M)higher scores mean a better outcome.
assessed at discharge 2weeks
Discharge 6 Weeks Exercise Capacity
Exercise capacity as assessed by 6 min walking test(M).The 6-min walk test (6 MWT) is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6-minute walk distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise . The 6 MWT provides information regarding functional capacity, response to therapy and prognosis across a broad range of chronic cardiopulmonary conditions .The normal range in aged patients 60-69 y(male 572 m,female 538 M),70-79 y(male 527 m,female 471 M),80-89 y(male 417 m,female 392 M)higher scores mean a better outcome.
assessed at discharge.6weeks
Discharge 12 Weeks Exercise Capacity
Exercise capacity as assessed by 6 min walking test(M).The 6-min walk test (6 MWT) is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6-minute walk distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise . The 6 MWT provides information regarding functional capacity, response to therapy and prognosis across a broad range of chronic cardiopulmonary conditions .The normal range in aged patients 60-69 y(male 572 m,female 538 M),70-79 y(male 527 m,female 471 M),80-89 y(male 417 m,female 392 M).higher scores mean a better outcome.
assessed at discharge 12 weeks
Secondary Outcomes (27)
Discharge 2 Weeks Forced Vital Capacity (FVC in Liter(L)/Sec)
assessments at 2 weeks after discharge
Discharge 2weeks Forced Expiratory Volume in 1 Second(FEV1,Liter(L)/Sec)
assessed at 2 weeks after discharge
Discharge 2weeks MMEF 25-75%(Liter(L)/Sec)
assessed at discharge 2weeks
Discharge 2weeks Peak Expiratory Flow Rate(PEFR , Liter(L)/Sec)
assessed at discharge 2weeks
Discharge 2weeks Inspiratory Muscle Strength(MIP,cmH2O)
assessed at discharge 2 weeks.
- +22 more secondary outcomes
Study Arms (2)
Home-based rehabilitation program
EXPERIMENTAL0-2 weeks,1. aerobic exercise intensity was targeted to reach 10-11 points of perceived exercise (RPE) scale 2. raised their upper limbs while simultaneously performing lower-limb stepping at place for 20 min 3.walked at a comfortable speed for 15 min twice per day.4. Triflo-II was performed 8-10 times per hour. inspiratory muscle training with the initial pressure set at 25%-30% of the maximum inspiratory pressure.3-6 weeks, aerobic exercise reach 12-15 points on the RPE scale. upper-limb resistance exercise (raising of a 250-cc water bottle) and lower-limb stepping for 20 min per day , walking exercise for a total of 30 min. Triflo-II was performed 8-10 times per hour, and train the inspiratory muscle with the pressure intensity adjusted to more than 5% of that in the first stage.
standard care
ACTIVE COMPARATORcontrol group accept the pulmonary rehabilitation (breathing exercise, extremities exercise, breathing muscle training, incentive spirometry (Triflo-II) training, intermittent positive pressure ventilation, chest physical therapy and pain control) only in operation stage on before op-day 3 day and after op-day and without home based pulmonary rehabilitation.
Interventions
(1) breathing exercises (pursed-lip and diaphragmatic breathing) and coughing exercises, (2) aerobic exercises (upper and lower limb exercises and walking), (3) incentive spirometry training (Triflo-II), and (4) threshold load training of the inspiratory muscle. In the first stage (0-2 weeks), the aerobic exercise intensity was targeted to reach 10-11 points on the 20-point Borg rating of perceived exercise (RPE) scale. Patients raised their upper limbs while simultaneously performing lower-limb stepping at place for 20 min; in addition, they walked at a comfortable speed for 15 min twice per day. Incentive spirometry training (Triflo-II) was performed 8-10 times per hour. We used a threshold load trainer for inspiratory muscle training (30 breaths each time, twice per day) with the initial pressure set at 25%-30% of the maximum inspiratory pressure.
Eligibility Criteria
You may qualify if:
- Signed consent
- The men and women over the age of 65
- admission to undergo VATS.
- consciousness and ability to communicate
- ability to undergo 6 weeks of a home-based pulmonary rehabilitation program
You may not qualify if:
- refusal to participate
- unplanned emergency surgery
- hemodynamic instability
- received other surgery within a month postsurgery
- unconsciousness after surgery
- bedridden and upper or lower limb weakness
- received radiation and chemotherapy postsurgery
- implementation of thoracoscopic surgery for biopsy only
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Chang Gung Memorial Hospital
Kaohsiung City, Niaosong, 83342, Taiwan
Chang Gung Memorial Hospital
Kaohsiung City, 83342, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
First,sample size is low,this may affect the result of the study;secondly, pulmonary function should collect DLCO and MVV;third,although the patients were checked via telephone every week,there is no surefire way to enforce intervention.
Results Point of Contact
- Title
- Respiratory therapist Nai-Ying Kuo
- Organization
- Chang Gung Memorial Hospital
Study Officials
- STUDY DIRECTOR
Jui Fang Liu, PhD
Department of Respiratory Therapy
- STUDY CHAIR
Nai Ying Kuo, master
Department of Respiratory Therapy
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- After participants signed the consent form, they were randomly included into the control or experimental group on the day of discharge
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Respiratory therapist
Study Record Dates
First Submitted
April 12, 2016
First Posted
April 29, 2016
Study Start
March 31, 2016
Primary Completion
April 1, 2017
Study Completion
May 31, 2017
Last Updated
November 3, 2020
Results First Posted
November 3, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- starting 6 months after publication
- Access Criteria
- connect with miss Nai ying kuo and Share IPD by email
Share Protocol and Outcome deta